Cardiometabolic disease is a composite term encompassing a constellation of health conditions that collectively heighten the risk of both cardiovascular disease and metabolic disorders, presenting a formidable health challenge in contemporary society. This intricate cluster includes maladies such as dyslipidemia, insulin resistance, and abdominal obesity, all of which synergistically contribute to an increased susceptibility to heart disease and related complications. The complex interplay of genetic factors, environmental influences, and individual behaviors underscores the multifactorial nature of cardiometabolic diseases. Unhealthy dietary patterns, sedentary lifestyles, and a genetic predisposition can collectively propel the onset and progression of these interconnected conditions. Timely identification and the implementation of comprehensive management approaches are paramount in curbing the impact of cardiometabolic diseases. Emphasis on lifestyle modifications, medication adherence, and routine health assessments becomes imperative in fostering improved outcomes. Public health campaigns dedicated to awareness, education, and preventive interventions emerge as key components in tackling the growing prevalence of cardiometabolic disease and fostering a healthier and more resilient population.
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Beyond weight loss and diabetes control GLP 1 agonists paradigm shift in Cardiovascular care .
Syed Raza, Awali Hospital, Bahrain
Title : Vericiguat Inhibits the Progress of Cardiac Hypertrophy and Prevents Hypertrophy Induced Heart Failure by Multiple Mechanisms
Guo Wei He, TEDA International Cardiovascular Hospital, Tianjin University, China
Title : Coronary revascularization in patients with diabetes: Prospects for stenting in patients with type 1 diabetes and coronary artery disease
Mekhman N Mamedov, National Research Center for Therapy and Preventive Medicine, Russian Federation
Title : STEMI versus acute occlusive myocardial infarction: Which term should we use?
Yochai Birnbaum, Baylor College of Medicine, United States
Title : Chronic angina and the health economics of cardiovascular risk reduction in macro- and microvascular coronary disease
Uwe Peter Tigor, Auxilius Pharma, United States